Total n = 111 | Myocarditis (Group 1) (n = 20) | No myocarditis (Group 2) (n = 91) | p-value | |
---|---|---|---|---|
LVEF at admission (%) | 47.7 ± 13.4 | 44.6 ± 14.0 | 48.4 ± 13.2 | 0.256 |
LVEF% < 55% (no. of pts, %) | 72/111 (65) | 15/20 (75) | 57/91 (63) | 0.438 |
Lowest LVEF during hospitalisation (%) | 42.9 ± 10.9 | 44.5 ± 12.9 | 42.5 ± 10.5 | 0.576 |
RV dysfunction (no. of pts, %) | 18/84 (21) | 5/14 (36) | 13/70 (19) | 0.167 |
Diastolic dysfunction | 10/63 (16) | 2/12 (17) | 8/51 (16) | 0.999 |
Pericardial effusion (no. of pts, %) | 21/99 (19) | 3/18 (17) | 18/81 (22) | 0.756 |
Coronary dilation (no. of pts, %) | 17/98 (17) | 1/13 (8) | 16/85 (19) | 0.456 |
LVEF at discharge (%) | 61 (56–66) | 63 (53–68) | 61 (56–66) | 0.286 |
LVEF < 55% at discharge (no. of pts, %) | 15/71 (21) | 3/10 (30) | 12/61 (20) | 0.431 |
Duration between first ECHO and ECHO at last follow-up, days | 54 (38–123) | 54 (46–127) | 53 (36–123) | 0.571 |